Analysed KIORA PHARMACEUTICALS INC (KPRX:NASDAQ) News Sources
Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model
18-06-2026
yahoo.com
SS Innovations International (SSII) Appoints Sarah Romano as Chief Financial Officer
15-07-2026
yahoo.com
Kiora Pharmaceuticals Appoints Keith J. Lane as Executive Vice President of Global Clinical Development and Regulatory Affairs
08-09-2026
yahoo.com
Kiora's Phase 1 ABACUS Study of KIO-301 in Retinitis Pigmentosa Published in Nature Medicine; Phase 2 Trial Underway
14-04-2026
yahoo.com
Kiora Pharmaceuticals Announces Private Placement for Up to $24 Million Led by Perceptive Advisors
07-04-2026
yahoo.com
Kiora Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update
08-05-2026
yahoo.com
Kiora Pharmaceuticals to Participate in Piper Sandler Virtual Ophthalmology Symposium
02-07-2026
yahoo.com
What is the current price of KIORA PHARMACEUTICALS INC (KPRX:NASDAQ)?
The current price of KIORA PHARMACEUTICALS INC (KPRX:NASDAQ) is $2.54.
KIORA PHARMACEUTICALS INC (KPRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of KIORA PHARMACEUTICALS INC (KPRX:NASDAQ) since the previous trading day is $0.01.
KIORA PHARMACEUTICALS INC (KPRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of KIORA PHARMACEUTICALS INC (KPRX:NASDAQ) since the previous trading day is 0.3953%.
What is the most recent average sentiment score for KIORA PHARMACEUTICALS INC (KPRX:NASDAQ)?
The most recent average sentiment score for KIORA PHARMACEUTICALS INC (KPRX:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for KIORA PHARMACEUTICALS INC (KPRX:NASDAQ)?
The most recent sentiment for KIORA PHARMACEUTICALS INC (KPRX:NASDAQ) is .
SEC-8K** Filing Available For KIORA PHARMACEUTICALS INC (KPRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.